Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells

Miao, Yuxuan, Yang, Hanseul, Levorse, John, Yuan, Shaopeng, Polak, Lisa, Sribour, Megan, Singh, Bhuvanesh, Rosenblum, Michael D. +1 more·2019·Cell
DOI 10.1016/j.cell.2019.03.025

Cited by (303)

Items 301–303 of 303

  1. Targeting bromodomain and extra-terminal proteins reprograms macrophages and inhibits breast cancer progression
    Deeksha Sharma, Cody G. Hager, Grace G. Bushnell, Alexander P. Kalman, Grace F. Shapiro, Katherine A. Xendzova, Lynne Walenjus, Chloe M. Hutchens, Max S. Wicha, Monika Leigh Burness · 2026 · Frontiers in Immunology
  2. Roles of Mitochondrial Genome-Encoded Circular RNAs (mecciRNAs) in Human Diseases: Potential Biomarkers and Therapeutic Targets
    Zahra Firoozi, Abbas Shahi, Mohammadreza Sharifi, Ali Moravej, Saeed Mohammadi, Abdolreza Daraei, Hassan Dastsooz, Yaser Mansoori, Rasoul Salehi · 2026 · Biochemistry (Moscow)
  3. Reframing cancer therapy through tumor plasticity
    Akansha M. Shah, Bryan Marsh, Frédéric J. de Sauvage · 2026 · Nature Cancer